| Title |
Type |
Day |
Time |
Room |
| 187. Therapy in thoracic oncology |
Oral Presentation |
Monday |
08:30 - 10:30 |
Berlin |
| 188. Factors related to outcome of community-acquired pneumonia |
Oral Presentation |
Monday |
08:30 - 10:30 |
Room 5.2c |
| 189. New frontiers in noninvasive assessment of the lungs |
Oral Presentation |
Monday |
08:30 - 10:30 |
Europa 2 |
| 190. Environmental tobacco smoke and smoking ban |
Oral Presentation |
Monday |
08:30 - 10:30 |
Paris 1 |
| 191. Pulmonary vascular medicine |
Oral Presentation |
Monday |
08:30 - 10:30 |
Paris 2 |
| 192. New trends in interventional pulmonology |
Oral Presentation |
Monday |
08:30 - 10:30 |
Room 5.2a |
| 193. Clinical epidemiology of tuberculosis |
Oral Presentation |
Monday |
08:30 - 10:30 |
New York 1 |
| 194. Diagnostic aspects of sleep apnoea |
E-Communication Session |
Monday |
08:30 - 10:30 |
New York 2 |
| 195. Lung and bone marrow transplantation: miscellaneous |
E-Communication Session |
Monday |
08:30 - 10:30 |
New York 3 |
| 196. Risk factors for allergic asthma and allergic rhinitis |
E-Communication Session |
Monday |
08:30 - 10:30 |
London 1 |
| 197. Pleural diseases and interventions |
E-Communication Session |
Monday |
08:30 - 10:30 |
London 2 |
| 198. Border patrol: the alveolar barrier in lung injury |
E-Communication Session |
Monday |
08:30 - 10:30 |
London 3 |
| 205. Preschool wheezing: advances in diagnosis, phenotyping and therapy |
Oral Presentation |
Monday |
10:45 - 12:45 |
Berlin |
| 206. Lung, traffic and volcanoes |
Oral Presentation |
Monday |
10:45 - 12:45 |
Room 5.2c |
| 207. Novel mechanisms in the pathogenesis of pulmonary inflammation |
Oral Presentation |
Monday |
10:45 - 12:45 |
Europa 2 |
| 208. Alternatives for continuous positive airway pressure therapy in obstructive sleep apnoea |
Oral Presentation |
Monday |
10:45 - 12:45 |
Paris 1 |
| 209. Effects of rehabilitation in very disabled COPD patients |
Oral Presentation |
Monday |
10:45 - 12:45 |
Paris 2 |
| 210. Best of lung epithelial cells 2008 |
Oral Presentation |
Monday |
10:45 - 12:45 |
Room 5.2a |
| 211. Management of COPD |
Oral Presentation |
Monday |
10:45 - 12:45 |
New York 1 |
| 212. Mucociliary clearance, novel techniques and assessments, in adult, paediatric and mechanically ventilated patients |
E-Communication Session |
Monday |
10:45 - 12:45 |
New York 2 |
| 213. Diagnostic paediatric lung function: technical and clinical aspects |
E-Communication Session |
Monday |
10:45 - 12:45 |
New York 3 |
| 214. Inflammatory trigger mechanisms in asthma and COPD |
E-Communication Session |
Monday |
10:45 - 12:45 |
London 1 |
| 215. COPD epidemiology |
E-Communication Session |
Monday |
10:45 - 12:45 |
London 2 |
| 216. Treatment and outcome in hospitalised patients with community-acquired pneumonia |
E-Communication Session |
Monday |
10:45 - 12:45 |
London 3 |
| 218. Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-1 |
| 219. Interstitial lung disease in systemic and vascular disorders |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-2 |
| 220. Acute lung injury and weaning |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-3 |
| 221. Mechanical ventilation and airway management |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-4 |
| 222. Noninvasive mechanical ventilation in the acute setting |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-5 |
| 223. Noninvasive ventilation in the chronic setting |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-6 |
| 224. Basic science in asthma and COPD II |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-7 |
| 225. Airway infection and host defence |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-8 |
| 226. Improving asthma and anti-allergic therapy |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-9 |
| 227. Understanding allergic airway inflammation with the help of animal models |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-10 |
| 228. Epidemiology of respiratory symptoms and COPD |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-11 |
| 229. Smoking cessation and new tobacco uses |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-12 |
| 230. Risk factors for childhood asthma and allergy |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-13 |
| 231. Pleuropulmonary infections; thoracic trauma |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-14 |
| 232. Diagnostic and therapeutic problems in thoracic surgery |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-15 |
| 233. Mediastinal lesions; rare pathology |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-16 |
| 234. Surgical treatment of lung tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-17 |
| 235. Donor organs and complications after lung transplantation |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-18 |
| 236. Beyond spirometry: the skills behind lung function testing |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-19 |
| 237. Diagnostic tests in lower respiratory tract infections |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-20 |
| 238. Lower respiratory tract infection: from outbreak to prognostic tests |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-21 |
| 239. Community-acquired pneumonia: prognosis, complications and prevention |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-22 |
| 240. Aetiology of respiratory infections: mycobacteria and fungi |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-23 |
| 241. Mechanisms of respiratory infections: interaction between the pathogen and the host |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-24 |
| 242. Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-25 |
| 243. Clinical epidemiology of tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-26 |
| 244. Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-27 |
| 245. Problems in managing pulmonary and extrapulmonary tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-28 |
| 246. Diagnosis of tuberculosis: problems and perspectives |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-29 |
| 247. Outcomes of tuberculosis treatment |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-30 |
| 248. Specific tuberculosis management problems in children and adolescents |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-31 |
| 249. Clinical epidemiology of tuberculosis I |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-32 |
| 250. Clinical epidemiology of tuberculosis II |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-33 |
| 251. Clinical epidemiology of tuberculosis III |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-34 |
| 252. The challenge of multidrug-resistant tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-35 |
| 253. Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-36 |
| 254. Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-37 |
| 255. Difficult tuberculosis cases |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-38 |
| 256. Various thoracic tumours and interesting cases |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-39 |
| 257. Biology and prognosis in thoracic oncology |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-40 |
| 258. Diagnostic aspects in thoracic oncology |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-41 |
| 259. Treatment of thoracic tumours |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-42 |
| 260. Various aspects of thoracic oncology |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-43 |
| 261. Impact of patient education on cost-effectiveness of treatment |
Thematic Poster Session |
Monday |
12:50 - 14:40 |
Hall 6.2-44 |
| 266. Clinical trial - The effects of an anti-IL-13 human monoclonal antibody, IMA-638, on allergen-induced airway responses in subjects with mild atopic asthma |
Symposium |
Monday |
13:00 - 14:00 |
Helsinki |
| 287. Novel treatments for respiratory disease |
Oral Presentation |
Monday |
14:45 - 16:45 |
Berlin |
| 288. Rehabilitation and influencing factors |
Oral Presentation |
Monday |
14:45 - 16:45 |
Room 5.2c |
| 289. Biomarkers and antibiotic treatment of exacerbations of COPD |
Oral Presentation |
Monday |
14:45 - 16:45 |
Europa 2 |
| 290. Genetic risk factors for asthma and COPD |
Oral Presentation |
Monday |
14:45 - 16:45 |
Paris 1 |
| 291. Pulmonary infections in children - rare but important aspects |
Oral Presentation |
Monday |
14:45 - 16:45 |
Paris 2 |
| 292. Pathogenesis of obstructive sleep apnoea |
Oral Presentation |
Monday |
14:45 - 16:45 |
Room 5.2a |
| 293. Discovery of novel targets in lung disease by means of functional genomics |
Oral Presentation |
Monday |
14:45 - 16:45 |
New York 1 |
| 294. Asthma control or asthma severity |
E-Communication Session |
Monday |
14:45 - 16:45 |
New York 2 |
| 295. Integrated care and long-term strategies |
E-Communication Session |
Monday |
14:45 - 16:45 |
New York 3 |
| 296. Congenital lung lesions and emphysema; lung cancer surgery |
E-Communication Session |
Monday |
14:45 - 16:45 |
London 1 |
| 297. New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment |
E-Communication Session |
Monday |
14:45 - 16:45 |
London 2 |
| 298. Cystic fibrosis: new mechanisms, monitoring and treatment tools |
E-Communication Session |
Monday |
14:45 - 16:45 |
London 3 |